Skip to main content
SpringerLink
Log in

NSAID cardiovascular risk in diabetic patients not impacted by HbA1c level

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population-based cohort study Pharmacoepidemiology and Drug Safety : 9 Jun 2023. Available from: URL: https://doi.org/10.1002/pds.5652

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NSAID cardiovascular risk in diabetic patients not impacted by HbA1c level. Reactions Weekly 1967, 9 (2023). https://doi.org/10.1007/s40278-023-43816-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-43816-9

Search

Navigation